MAPK3 and cancer: Interestingly, in several nonurothelial cancer cells, cooperation of GABBR2 with EGFR-ERK1/2 signaling has been documented [35,36,37,38,44], while the ERK1/2 pathway has been linked to CDDP resistance [29,45].